Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDRY.L Share News (SDRY)

  • There is currently no data for SDRY

SVM UK Emerging Fund Reports Decrease In Net Asset Value In Full Year

Tue, 09th Jul 2019 15:05

(Alliance News) - SVM UK Emerging Fund PLC on Tuesday reported a decline in net asset value per share in its most recently ended financial year.

The investment firm said its NAV per share decreased over the 12 months to the end of March to 110.06 pence from 112.05p reported a year earlier.

SVM UK Emerging Fund's NAV total return was negative 1.8% and the share price total return was negative 6.7%. In comparison, the company's benchmark, the IA UK All Cos Sector Average Index, returned positive 2.8% over the same period.

During the 12 months, there were positive contributions to performance from online retailer Ocado Group PLC, drinks mixer maker Fevertree Drinks PLC, legal finance provider Burford Capital Ltd, legal service provider Knights Group Holdings PLC, investor Aquis Exchange PLC, promotional merchandise firm 4Imprint Group PLC and litigation financing company Manolete Partners PLC, SVM UK Emerging Fund noted.

In contrast, the main "disappointments" in the period were fashion retailers ASOS PLC and Superdry PLC, online booking platform Hostelworld Group PLC and gambling firm GVC Holdings PLC.

"The portfolio emphasises exposure to scalable businesses with a competitive edge and potential for self-help that can deliver above average growth," said Chair Peter Dicks.

The trust's share price as at March 31 stood at 84.00 pence, representing a 24% discount to NAV.

SVM UK Emerging Fund shares were trading 1.5% lower on Tuesday afternoon at 91.56p each in London.

Related News

UK's FTSE 100 hits over three-week low as banks, energy stocks sag
1 day ago

UK's FTSE 100 hits over three-week low as banks, energy stocks sag

June 9 (Reuters) - Britain's ​blue-chip FTSE ⁠100 hit its lowest since mid-May ​on Tuesday, bogged down by losses in heavyweight lenders HSBC and Stan...

Fevertree Drinks extends share buyback after solid start to year
1 day ago

Fevertree Drinks extends share buyback after solid start to year

(Alliance News) - Fevertree Drinks PLC on Tuesday announced a GBP30 million extension to its share buyback programme and said it remains confident of ...

Fever-Tree toasts strong start to the year, shares fizz
1 day ago

Fever-Tree toasts strong start to the year, shares fizz

(Sharecast News) - Shares in Fever-Tree Drinks fizzed on Tuesday, after the British business reaffirmed its full-year outlook and extended its share b...

SDRY.L News

SMALL-CAP WINNERS & LOSERS: Wincanton lifts outlook on strong quarter
20 Jan 2022

SMALL-CAP WINNERS & LOSERS: Wincanton lifts outlook on strong quarter

SMALL-CAP WINNERS & LOSERS: Wincanton lifts outlook on strong quarter

UK earnings, trading statements calendar - next 7 days
13 Jan 2022

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

LONDON MARKET CLOSE: Stocks fall as Omicron variant fears mount
2 Dec 2021

LONDON MARKET CLOSE: Stocks fall as Omicron variant fears mount

LONDON MARKET CLOSE: Stocks fall as Omicron variant fears mount

SMALL-CAP WINNERS & LOSERS: Halfords buoyed by acquisition of National
2 Dec 2021

SMALL-CAP WINNERS & LOSERS: Halfords buoyed by acquisition of National

SMALL-CAP WINNERS & LOSERS: Halfords buoyed by acquisition of National

RBC Capital Markets ups Superdry to 'outperform'
2 Dec 2021

RBC Capital Markets ups Superdry to 'outperform'

(Sharecast News) - RBC Capital Markets upgraded Superdry to 'outperform' from 'sector perform' on Thursday, lifting the price target to 425p from 390p...

LONDON BROKER RATINGS: Upgrades for Old Mutual and Superdry; Drax cut
2 Dec 2021

LONDON BROKER RATINGS: Upgrades for Old Mutual and Superdry; Drax cut

LONDON BROKER RATINGS: Upgrades for Old Mutual and Superdry; Drax cut

LONDON BRIEFING: GlaxoSmithKline's Covid treatment copes with Omicron
2 Dec 2021

LONDON BRIEFING: GlaxoSmithKline's Covid treatment copes with Omicron

LONDON BRIEFING: GlaxoSmithKline's Covid treatment copes with Omicron

SMALL-CAP WINNERS & LOSERS: UK leisure stocks shaken by variant fears
30 Nov 2021

SMALL-CAP WINNERS & LOSERS: UK leisure stocks shaken by variant fears

SMALL-CAP WINNERS & LOSERS: UK leisure stocks shaken by variant fears